| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB100-56708SS | |||
| Azide and BSA Free | NBP2-33244 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | 1967-NG-100/CF | |||
| Conjugate | Catalog # | Availability | Size | Price |
|---|---|---|---|---|
| Biotin | NBP1-42761 | |||
| HRP | NBP1-42762 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NB600-1131SS | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Low Endotoxin, Azide and BSA Free | NBP2-75925SS | |||
![Western Blot: Mouse Monoclonal Caspase-3 Antibody (31A1067) - (Pro and Active) [IMGENEX: IMG-144A] [NB100-56708] - Whole cell lysates from MDA-MB-231, MCF-7, SUM149 and SUM159 cells were loaded with 50 ug/lane. 10% SDS-PAGE. Caspase-3 Antibody (NB100-56708) was used for primary antibody: 1:2000, 4℃, overnight. Image from a verified customer review.](http://images.novusbio.com/fullsize/antibody/nb100-56708_mouse-monoclonal-caspase-3-antibody-31a1067-pro-and-active-imgenex-img-144a-western-blot-3112024145834..png)
![Immunocytochemistry/ Immunofluorescence: Caspase-3 Antibody (31A1067) - (Pro and Active) - BSA Free [NB100-56708] - rOPN administration influenced the interaction & balance between Beclin 1 & Caspase‐3 at 24 h after SAH. Double immunofluorescence staining of Caspase‐3 & Beclin 1 in Sham group, SAH + Vehicle group & SAH + rOPN group at 24 h after SAH induction. Sample size is 9, n = 3 per group. Localization of Caspase‐3 can be cytoplasmic & nuclear. Staining in the nucleus is considered to be an indication of active Caspase‐3. The dashed lines & the red box on brain slice images indicate the locations observed. Vehicle, phosphate‐buffered saline; Scale bar = 50 μm Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/31436915), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nb100-56708_mouse-monoclonal-caspase-3-antibody-31a1067-pro-and-active-310202415175231.jpg)
![Western Blot: Caspase-3 Antibody (31A1067) - (Pro and Active) - BSA Free [NB100-56708] - PEM induces YIPF2 upregulation & apoptosis in NSCLC cells.a, b H1792 (a) & H1299 (b) NSCLC cells were treated with PEM at various concentrations (0–10.0 μM) for 36 h. Cell lysates were analyzed by Western blotting with antibodies against YIPF2 & ACTB. c Overexpression of YIPF2 in H1299 cells in the presence or absence of PEM at 5.0 μM for 36 h. Cell lysates were analyzed by Western blotting with antibodies against YIPF2, CASP8, CASP3, PARP1 & ACTB. d Knockdown of YIPF2 expression by YIPF2–1 siRNA in A549 NSCLC cells in the presence or absence of PEM at 5.0 μM for 36 h. Cell lysates were analyzed by Western blotting with antibodies against YIPF2, CASP8, CASP3, PARP1 & ACTB. Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/32303681), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nb100-56708_mouse-monoclonal-caspase-3-antibody-31a1067-pro-and-active-310202415175219.jpg)
![Western Blot: Caspase-3 Antibody (31A1067) - (Pro and Active) - BSA Free [NB100-56708] - PEM induces YIPF2 upregulation & apoptosis in NSCLC cells.a, b H1792 (a) & H1299 (b) NSCLC cells were treated with PEM at various concentrations (0–10.0 μM) for 36 h. Cell lysates were analyzed by Western blotting with antibodies against YIPF2 & ACTB. c Overexpression of YIPF2 in H1299 cells in the presence or absence of PEM at 5.0 μM for 36 h. Cell lysates were analyzed by Western blotting with antibodies against YIPF2, CASP8, CASP3, PARP1 & ACTB. d Knockdown of YIPF2 expression by YIPF2–1 siRNA in A549 NSCLC cells in the presence or absence of PEM at 5.0 μM for 36 h. Cell lysates were analyzed by Western blotting with antibodies against YIPF2, CASP8, CASP3, PARP1 & ACTB. Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/32303681), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nb100-56708_mouse-monoclonal-caspase-3-antibody-31a1067-pro-and-active-310202415371987.jpg)
![Immunocytochemistry/ Immunofluorescence: Caspase-3 Antibody (31A1067) - (Pro and Active) - BSA Free [NB100-56708] - Lipofection of top broccoletti-miR candidates does not influence basal & induced apoptosis.(A) BxPc-3 & Bx-Gem cells were transfected as described in Figure 3. Seventy-two hours later, the cells were stained with Annexin V-PE & 7-AAD, followed by FACS analysis. The percentage of Annexin V- & 7-AAD-positive cells is shown. (B) Lipofected BxPc-3 & Bx-Gem cells were stained with an antibody specific for the proliferation marker Ki-67 (green) or the apoptosis marker cleaved fragment of caspase-3 (red), which indicates apoptosis. Representative images at ×100 magnification are shown. The percentage of Ki-67- or caspase-3-positive cells was counted in 18 visual fields, & the means ± SD are shown in the diagram below. (C) BxPc-3 & Bx-Gem were lipofected as described above, & at 24 h later, the cells were treated with gemcitabine (10 nM) or were left untreated. Ninety-six hours after gemcitabine treatment, viability was determined by MTT assay. The data are presented as the means ± SD (**P < 0.01). Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/32292571), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nb100-56708_mouse-monoclonal-caspase-3-antibody-31a1067-pro-and-active-31020241612697.jpg)
![Western Blot: Caspase-3 Antibody (31A1067) - (Pro and Active) - BSA Free [NB100-56708] - PEM induces apoptosis of NSCLC cells via YIPF2-TNFRSF10B axis.a, b A549 (a) & H1792 (b) cells were treated with PEM at 5.0 μM for the indicated times (0, 6, 12, 24, 36 & 48 h). Cell lysates were analyzed by Western blotting with antibodies against YIPF2, TNFRSF10B & ACTB. c A549 cells were treated with doxorubicin (DOX) at various concentrations (0–2.0 μM) for 18 h. Cell lysates were analyzed by Western blotting with antibodies against YIPF2, TNFRSF10B & ACTB. d Overexpression of YIPF2 in H1792 & H1299 cells in the presence or absence of PEM at 5.0 μM for 36 h. Cell lysates were analyzed by Western blotting with antibodies against YIPF2, TNFRSF10B & ACTB. e Knockdown of YIPF2 expression by YIPF2–1 siRNA in A549 & H1792 cells in the presence or absence of PEM at 5.0 μM for 36 h. Cell lysates were analyzed by Western blotting with antibodies against YIPF2, TNFRSF10B & ACTB. f Overexpression of YIPF2 in H1299 cells (left) or Knockdown of YIPF2 expression by YIPF2–1 siRNA in H1792 cells (right) in the presence or absence of PEM at 5.0 μM for 36 h. Cell lysates were analyzed by Western blotting with antibodies against YIPF2, TNFRSF10A & ACTB. g Three A549 cell lines (Ctrl, YIPF2, YIPF2 + siTNFRSF10B) in the presence or absence of PEM at 5.0 μM for 36 h. Cell lysates were analyzed by Western blotting with antibodies against YIPF2, TNFRSF10B, CASP8, CASP3 & ACTB. h Three H1299 cell lines (Ctrl, siYIPF2–1, siYIPF2–1 + TNFRSF10B (short isoform)) in the presence or absence of PEM at 5.0 μM for 36 h. Cell lysates were analyzed by Western blotting with antibodies against YIPF2, TNFRSF10B, CASP8, CASP3 & ACTB. Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/32303681), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nb100-56708_mouse-monoclonal-caspase-3-antibody-31a1067-pro-and-active-3102024155528.jpg)
![Immunocytochemistry/ Immunofluorescence: Caspase-3 Antibody (31A1067) - (Pro and Active) - BSA Free [NB100-56708] - Cell numbers positively stained for NeuN, DCX, PCNA & caspase-3 in the subgranular region of the dentate gyrus in WT & RanBP9−/− (KO) mice.(A), DAPI-stained brain sections to show the highlighted subgranular zone within the dentate gyrus region of the hippocampus used for cell counts shown in B. (B), Representative brain sections stained with anti-NeuN, anti-DCX, anti-PCNA, anti-capsase-3 & counter stained with DAPI. Cell counting revealed significantly decreased numbers of NeuN positive cells in RanBP9−/− (KO) brains (22%) compared to WT controls. However DCX, PCNA & caspase positive cell numbers were not significantly altered. In each group, n = 3, data presented as mean± SEM. **, p<0.01 by Student’s t-test. Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/23840553), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nb100-56708_mouse-monoclonal-caspase-3-antibody-31a1067-pro-and-active-3102024155450.jpg)
![Western Blot: Caspase-3 Antibody (31A1067) - (Pro and Active) - BSA Free [NB100-56708] - NFATc1 regulates DcR3 expression at a transcriptional level. (A,B) Immunoblot analysis of whole-cell lysates & quantitative real-time-PCR assaying relative DcR3 mRNA expression of ACHN & 769-P cells 24 h after treatment with cyclosporin A (CsA, 25 μM) or Tacrolimus (FK-506, 50 μM) (A); 48 h post transfection with NFATc1 or an empty vector control (neo) (B). Expression data were normalized to internal 18S rRNA expression (mean ± SEM; n=3; *p<0.05, **p<0.01, ***p<0.001; T-test). (C) Immunoblot analysis of cytoplasmic & nuclear fractions of ACHN & 769-P cells after treatment with LY294002 (50 μM), Everolimus (1 μM), or Cyclosporine A (25 μM). (D) Relative NFATc1–luciferase reporter activity of ACHN & 769-P cells 24 h post transfection with myrAkt or an empty vector control (neo) (mean ± SEM; n=3; *p<0.05, **p<0.01; T-test). Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/24107265), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nb100-56708_mouse-monoclonal-caspase-3-antibody-31a1067-pro-and-active-3102024155373.jpg)
![Western Blot: Caspase-3 Antibody (31A1067) - (Pro and Active) - BSA Free [NB100-56708] - rOPN administration elevated the expression of autophagy‐related proteins while suppressing apoptosis in rat brain at 24 h after SAH. The effects of rOPN on expression levels of (A) Beclin 1, mean ± SD is 1.016 ± 0.2262 in Sham group, 2.874 ± 1.147 in SAH + Vehicle group, 4.963 ± 2.05 in SAH + rOPN group, F = 15.52, (B) ATG5, mean ± SD is 0.8908 ± 0.2545 in Sham group, 2.332 ± 0.6431 in SAH + Vehicle group, 4.364 ± 1.309 in SAH + rOPN group, F = 25.02, (C) LC3, mean ± SD is 1 ± 0.1845 in Sham group, 1.755 ± 0.3017 in SAH + Vehicle group, 2.7 ± 0.7957 in SAH + rOPN group, F = 17.23, (D) Cleaved Caspase‐3, mean ± SD is 1.008 ± 0.186 in Sham group, 4.112 ± 1.528 in SAH + Vehicle group, 2.291 ± 0.6268 in SAH + rOPN group, F = 15.86, (E) Bax, mean ± SD is 1.006 ± 0.321 in Sham group, 37.47 ± 10.86 in SAH + Vehicle group, 23.83 ± 8.143 in SAH + rOPN group, F = 33.13, (F) Bcl‐2, mean ± SD is 1.005 ± 0.2736 in Sham group, 0.2309 ± 0.1257 in SAH + Vehicle group, 0.7843 ± 0.2278 in SAH + rOPN group, F = 20.1, in the left hemisphere of rat brain at 24 h after SAH. Sample size is 18, n = 6 per group. Data were presented as mean ± SD. *P < .05, ***P < .001 vs Sham group; #P < .05, ##P < .01 vs SAH + Vehicle group Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/31436915), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nb100-56708_mouse-monoclonal-caspase-3-antibody-31a1067-pro-and-active-31020241552392.jpg)
![Western Blot: Caspase-3 Antibody (31A1067) - (Pro and Active) - BSA Free [NB100-56708] - RAB8 suppresses PEM-induced apoptosis of NSCLC cells by promoting the removing of TNFRSF10B from plasma membrane to cytoplasm.a, b Knockdown of RAB8 expression by RAB8 siRNA in H1792 (a) & A549 (b) cells in the presence or absence of PEM at 5.0 μM for 36 h. The surface expression of TNFRSF10B was confirmed by flow cytometry analyses. c Overexpression of RAB8 in H1299 cells in the presence or absence of PEM at 5.0 μM for 36 h. Cell lysates were analyzed by Western blotting with antibodies against RAB8, TNFRSF10B, CASP8, CASP3, PARP1 & ACTB. d Knockdown of RAB8 expression by RAB8 siRNA in H1792 cells in the presence or absence of PEM at 5.0 μM for 36 h. Cell lysates were analyzed by Western blotting with antibodies against RAB8, TNFRSF10B, CASP8, CASP3, PARP1 & ACTB. Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/32303681), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nb100-56708_mouse-monoclonal-caspase-3-antibody-31a1067-pro-and-active-31020241612680.jpg)
![Western Blot: Caspase-3 Antibody (31A1067) - (Pro and Active) - BSA Free [NB100-56708] - RAB8 suppresses PEM-induced apoptosis of NSCLC cells by promoting the removing of TNFRSF10B from plasma membrane to cytoplasm.a, b Knockdown of RAB8 expression by RAB8 siRNA in H1792 (a) & A549 (b) cells in the presence or absence of PEM at 5.0 μM for 36 h. The surface expression of TNFRSF10B was confirmed by flow cytometry analyses. c Overexpression of RAB8 in H1299 cells in the presence or absence of PEM at 5.0 μM for 36 h. Cell lysates were analyzed by Western blotting with antibodies against RAB8, TNFRSF10B, CASP8, CASP3, PARP1 & ACTB. d Knockdown of RAB8 expression by RAB8 siRNA in H1792 cells in the presence or absence of PEM at 5.0 μM for 36 h. Cell lysates were analyzed by Western blotting with antibodies against RAB8, TNFRSF10B, CASP8, CASP3, PARP1 & ACTB. Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/32303681), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nb100-56708_mouse-monoclonal-caspase-3-antibody-31a1067-pro-and-active-31020241682182.jpg)
![Western Blot: IL-1 beta/IL-1F2 Antibody [NB600-633] - Methylene blue (M) inhibits NLRP3 inflammasome formation in post-spinal cord injury (SCI) microglia compared to sham (V). Expression of pro-IL-1B and mature IL-1B in microglia sorted from post-SCI spinal cords. Representative Western blot images are shown in (B). Image collected and cropped by CiteAb from the following publication (//journal.frontiersin.org/article/10.3389/fncel.2017.00391/full) licensed under a CC-BY license.](http://images.novusbio.com/fullsize/IL-1-beta-IL-1F2-Antibody-Western-Blot-NB600-633-img0012.jpg "<b>Biological Strategies Validation. </b>Western Blot: IL-1 beta/IL-1F2 Antibody [NB600-633] - Methylene blue (M) inhibits NLRP3 inflammasome formation in post-spinal cord injury (SCI) microglia compared to sham (V). Expression of pro-IL-1B and mature IL-1B in microglia sorted from post-SCI spinal cords. Representative Western blot images are shown in (B). Image collected and cropped by CiteAb from the following publication (//journal.frontiersin.org/article/10.3389/fncel.2017.00391/full) licensed under a CC-BY license.")
![<b>Biological Strategies Validation. </b>Immunocytochemistry/Immunofluorescence: IL-1 beta/IL-1F2 Antibody [NB600-633] - Trabecular Meshwork (TM) region of pig eyes were stained with IL-1 beta antibody (red). Image from verified customer review.](http://images.novusbio.com/fullsize/IL-1-beta-IL-1F2-Antibody-Immunocytochemistry-Immunofluorescence-NB600-633-img0009.jpg)
![Immunohistochemistry: IL-1 beta/IL-1F2 Antibody [NB600-633] - Analysis of: Human IL1beta antibody Secondary antibody: Peroxidase goat anti-rabbit at 1:10,000 for 45 min at RT Localization: cytoplasm Staining: Close up of medullary lymph node: positive staining in the cytoplasm of circulating macrophages. Neg Ctr (far right) normal rabbit IgG with pH 6.2 40X](http://images.novusbio.com/fullsize/IL-1-beta-IL-1F2-Antibody-Immunohistochemistry-NB600-633-img0010.jpg)
![Western Blot: IL-1 beta/IL-1F2 Antibody [NB600-633] - Analysis of IL-1 beta in Rhesus fetal membrane using anti-IL-1 beta antibody. Image from verified customer review.](http://images.novusbio.com/fullsize/IL-1-beta-IL-1F2-Antibody-Western-Blot-NB600-633-img0005.jpg)
![Western Blot: IL-1 beta/IL-1F2 Antibody [NB600-633] - Antibody was used at a 1:200 dilution incubated 1h at room temperature to detect dog IL-1b by Western blot. Lane 1 and 2 were loaded with 2.5 ug and 500 ng of dog IL-1b respectively. The molecular weight of the detected band is estimated by comparison to molecular weight markers (not shown). Detection occurred using a 1:3,000 dilution of IRDye (TM) 800 conjugated Donkey anti-Rabbit IgG for 1h at room temperature.](http://images.novusbio.com/fullsize/IL-1-beta-IL-1F2-Antibody-Western-Blot-NB600-633-img0006.jpg)
![Western Blot: IL-1 beta/IL-1F2 Antibody [NB600-633] - pro-IL-1beta in glioblastoma cells. Image from verified customer review.](http://images.novusbio.com/fullsize/IL-1-beta-IL-1F2-Antibody-Western-Blot-NB600-633-img0008.jpg)
![Western Blot: IL-1 beta/IL-1F2 Antibody [NB600-633] - Lane 1: Human IL-1Beta. Load: 5 ng per lane. Primary antibody: Human IL-1Beta antibody at 1:2,000 for overnight at 4C. Secondary antibody: Peroxidase rabbit secondary antibody at 1:40,000 for 30 min at RT. Block: Blocking Buffer for Fluorescent Western Blotting for 30 min at RT. Predicted/Observed size: 17 kDa, 17 kDa for Human IL-1Beta. Other band(s): Unspecific band at 35 kDa.](http://images.novusbio.com/fullsize/IL-1-beta-IL-1F2-Antibody-Western-Blot-NB600-633-img0011.jpg)
![Western Blot: IL-1 beta/IL-1F2 Antibody [NB600-633] - Methylene blue inhibits inflammasome formation in cultured microglia. (A) Expression of Pro-Caspase-1, Caspase-1 p20, pro-IL-1 beta & mature IL-1 beta in microglia with or without stimulation in the presence or absence of methylene blue. Left: representative Western blot images. Right: statistics. N = 5 per group. The (B) expression of NLRP3, NLRC4 & Aim2 in microglia. Left: representative Western blot images. Right: statistics. N = 4 per group. (C) Co-immunoprecipitation assay showing the binding of ASC to NLRP3 or NLRC4. Left: representative Western blot images. Right: statistics. Un: no stimulation. LPS+ATP: stimulation with LPS followed by ATP treatment. V: vehicle; M: 500 nM methylene blue. IP: immunoprecipitation with the antibody against indicated protein. IB: detection of indicated protein. To analyze the relative expression of target proteins, the band intensities of target proteins were normalized to corresponding band intensities of alpha -Tubulin, followed by calculating the expression in other groups relative to “Un (V)” group. N = 4 per group. *p < 0.05; **p < 0.01; ***p < 0.001 in comparison with unstimulated cells of the vehicle group. #p < 0.05; ##p < 0.01 in comparison with stimulated cells of the vehicle group. Image collected & cropped by CiteAb from the following publication (//journal.frontiersin.org/article/10.3389/fncel.2017.00391/full), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nb600-633_rabbit-polyclonal-il-1-beta-il-1f2-antibody-310202416165633.jpg)
![Western Blot: Rabbit Polyclonal IL-1 beta/IL-1F2 Antibody [NB600-633] - IL-1 beta/IL-1F2 Western blot of liver homogenate from control (1) and alcohol-fed mice (2). Image from a verified customer review.](http://images.novusbio.com/fullsize/antibody/nb600-633_rabbit-polyclonal-il-1-beta-il-1f2-antibody-western-blot-25112024153834..png)
![Immunohistochemistry: Human Prostate Tissue MicroArray (Cancer) [NBP2-30169] - Adenocarcinoma patient - Gleason score 7. RED: HDAC6. BLUE: DAPI, nucleus. IHC image submitted by a verified customer review.](http://images.novusbio.com/fullsize/Human-Prostate-Tissue-MicroArray-Cancer-Immunohistochemistry-NBP2-30169-img0100.jpg "Immunohistochemistry: Human Prostate Tissue MicroArray (Cancer) [NBP2-30169] - Adenocarcinoma patient - Gleason score 7. RED: HDAC6. BLUE: DAPI, nucleus. IHC image submitted by a verified customer review.")
![Immunohistochemistry: Human Prostate Tissue MicroArray (Cancer) [NBP2-30169] - Human prostate cancer tissue stained with rabbit anti-ALDH1A1 antibody. Gleason score 7. Image taken with EVOS M5000 Imaging System. IHC image submitted by a verified customer review.](http://images.novusbio.com/fullsize/Human-Prostate-Tissue-MicroArray-Cancer-Immunohistochemistry-NBP2-30169-img0101.jpg)
![Immunohistochemistry: Human Prostate Tissue MicroArray (Cancer) [NBP2-30169] - Prostate cancer tissue IHC stained with anti-E-cadherin antibody - brown, nucleus is stained by hematoxylin. Image from verified customer review.](http://images.novusbio.com/fullsize/Human-Prostate-Tissue-MicroArray-Cancer-Immunohistochemistry-NBP2-30169-img0102.jpg)
![Hematoxylin & Eosin Stain: Human Prostate Cancer Tissue MicroArray [NBP2-30169] - 01. Prostate Adenocarcinoma](http://images.novusbio.com/fullsize/Human-Prostate-Cancer-Tissue-MicroArray-Hematoxylin-&-Eosin-Stain-NBP2-30169-img0050.jpg)
![Hematoxylin & Eosin Stain: Human Prostate Cancer Tissue MicroArray [NBP2-30169] - 02. Prostate Adenocarcinoma](http://images.novusbio.com/fullsize/Human-Prostate-Cancer-Tissue-MicroArray-Hematoxylin-&-Eosin-Stain-NBP2-30169-img0051.jpg)
![Hematoxylin & Eosin Stain: Human Prostate Cancer Tissue MicroArray [NBP2-30169] - 03. Prostate Adenocarcinoma](http://images.novusbio.com/fullsize/Human-Prostate-Cancer-Tissue-MicroArray-Hematoxylin-&-Eosin-Stain-NBP2-30169-img0052.jpg)
![Hematoxylin & Eosin Stain: Human Prostate Cancer Tissue MicroArray [NBP2-30169] - 04. Prostate Adenocarcinoma](http://images.novusbio.com/fullsize/Human-Prostate-Cancer-Tissue-MicroArray-Hematoxylin-&-Eosin-Stain-NBP2-30169-img0053.jpg)
![Hematoxylin & Eosin Stain: Human Prostate Cancer Tissue MicroArray [NBP2-30169] - 05. Prostate adenocarcinoma](http://images.novusbio.com/fullsize/Human-Prostate-Cancer-Tissue-MicroArray-Hematoxylin-&-Eosin-Stain-NBP2-30169-img0054.jpg)
![Hematoxylin & Eosin Stain: Human Prostate Cancer Tissue MicroArray [NBP2-30169] - 06. Prostate adenocarcinoma](http://images.novusbio.com/fullsize/Human-Prostate-Cancer-Tissue-MicroArray-Hematoxylin-&-Eosin-Stain-NBP2-30169-img0055.jpg)
![Hematoxylin & Eosin Stain: Human Prostate Cancer Tissue MicroArray [NBP2-30169] - 07. Prostate adenocarcinoma](http://images.novusbio.com/fullsize/Human-Prostate-Cancer-Tissue-MicroArray-Hematoxylin-&-Eosin-Stain-NBP2-30169-img0056.jpg)
![Hematoxylin & Eosin Stain: Human Prostate Cancer Tissue MicroArray [NBP2-30169] - 08. Prostate adenocarcinoma](http://images.novusbio.com/fullsize/Human-Prostate-Cancer-Tissue-MicroArray-Hematoxylin-&-Eosin-Stain-NBP2-30169-img0057.jpg)
![Hematoxylin & Eosin Stain: Human Prostate Cancer Tissue MicroArray [NBP2-30169] - 09. Prostate adenocarcinoma](http://images.novusbio.com/fullsize/Human-Prostate-Cancer-Tissue-MicroArray-Hematoxylin-&-Eosin-Stain-NBP2-30169-img0058.jpg)
![Hematoxylin & Eosin Stain: Human Prostate Cancer Tissue MicroArray [NBP2-30169] - 10. Prostate adenocarcinoma](http://images.novusbio.com/fullsize/Human-Prostate-Cancer-Tissue-MicroArray-Hematoxylin-&-Eosin-Stain-NBP2-30169-img0060.jpg)
![Hematoxylin & Eosin Stain: Human Prostate Cancer Tissue MicroArray [NBP2-30169] - 11. Prostate adenocarcinoma](http://images.novusbio.com/fullsize/Human-Prostate-Cancer-Tissue-MicroArray-Hematoxylin-&-Eosin-Stain-NBP2-30169-img0061.jpg)
![Hematoxylin & Eosin Stain: Human Prostate Cancer Tissue MicroArray [NBP2-30169] - 12. Prostate adenocarcinoma](http://images.novusbio.com/fullsize/Human-Prostate-Cancer-Tissue-MicroArray-Hematoxylin-&-Eosin-Stain-NBP2-30169-img0062.jpg)
![Hematoxylin & Eosin Stain: Human Prostate Cancer Tissue MicroArray [NBP2-30169] - 13. Prostate adenocarcinoma](http://images.novusbio.com/fullsize/Human-Prostate-Cancer-Tissue-MicroArray-Hematoxylin-&-Eosin-Stain-NBP2-30169-img0063.jpg)
![Hematoxylin & Eosin Stain: Human Prostate Cancer Tissue MicroArray [NBP2-30169] - 14. Prostate adenocarcinoma](http://images.novusbio.com/fullsize/Human-Prostate-Cancer-Tissue-MicroArray-Hematoxylin-&-Eosin-Stain-NBP2-30169-img0064.jpg)
![Hematoxylin & Eosin Stain: Human Prostate Cancer Tissue MicroArray [NBP2-30169] - 15. Prostate adenocarcinoma](http://images.novusbio.com/fullsize/Human-Prostate-Cancer-Tissue-MicroArray-Hematoxylin-&-Eosin-Stain-NBP2-30169-img0065.jpg)
![Hematoxylin & Eosin Stain: Human Prostate Cancer Tissue MicroArray [NBP2-30169] - 16. Prostate adenocarcinoma](http://images.novusbio.com/fullsize/Human-Prostate-Cancer-Tissue-MicroArray-Hematoxylin-&-Eosin-Stain-NBP2-30169-img0066.jpg)
![Hematoxylin & Eosin Stain: Human Prostate Cancer Tissue MicroArray [NBP2-30169] - 17. Prostate adenocarcinoma](http://images.novusbio.com/fullsize/Human-Prostate-Cancer-Tissue-MicroArray-Hematoxylin-&-Eosin-Stain-NBP2-30169-img0067.jpg)
![Hematoxylin & Eosin Stain: Human Prostate Cancer Tissue MicroArray [NBP2-30169] - 18. Prostate adenocarcinoma](http://images.novusbio.com/fullsize/Human-Prostate-Cancer-Tissue-MicroArray-Hematoxylin-&-Eosin-Stain-NBP2-30169-img0068.jpg)
![Hematoxylin & Eosin Stain: Human Prostate Cancer Tissue MicroArray [NBP2-30169] - 19. Prostate adenocarcinoma](http://images.novusbio.com/fullsize/Human-Prostate-Cancer-Tissue-MicroArray-Hematoxylin-&-Eosin-Stain-NBP2-30169-img0069.jpg)
![Hematoxylin & Eosin Stain: Human Prostate Cancer Tissue MicroArray [NBP2-30169] - 20. Prostate adenocarcinoma](http://images.novusbio.com/fullsize/Human-Prostate-Cancer-Tissue-MicroArray-Hematoxylin-&-Eosin-Stain-NBP2-30169-img0070.jpg)
![Hematoxylin & Eosin Stain: Human Prostate Cancer Tissue MicroArray [NBP2-30169] - 21. Prostate adenocarcinoma](http://images.novusbio.com/fullsize/Human-Prostate-Cancer-Tissue-MicroArray-Hematoxylin-&-Eosin-Stain-NBP2-30169-img0071.jpg)
![Hematoxylin & Eosin Stain: Human Prostate Cancer Tissue MicroArray [NBP2-30169] - 22. Prostate adenocarcinoma](http://images.novusbio.com/fullsize/Human-Prostate-Cancer-Tissue-MicroArray-Hematoxylin-&-Eosin-Stain-NBP2-30169-img0072.jpg)
![Hematoxylin & Eosin Stain: Human Prostate Cancer Tissue MicroArray [NBP2-30169] - 23. Prostate adenocarcinoma](http://images.novusbio.com/fullsize/Human-Prostate-Cancer-Tissue-MicroArray-Hematoxylin-&-Eosin-Stain-NBP2-30169-img0073.jpg)
![Hematoxylin & Eosin Stain: Human Prostate Cancer Tissue MicroArray [NBP2-30169] - 24. Prostate adenocarcinoma](http://images.novusbio.com/fullsize/Human-Prostate-Cancer-Tissue-MicroArray-Hematoxylin-&-Eosin-Stain-NBP2-30169-img0074.jpg)
![Hematoxylin & Eosin Stain: Human Prostate Cancer Tissue MicroArray [NBP2-30169] - 25. Prostate adenocarcinoma](http://images.novusbio.com/fullsize/Human-Prostate-Cancer-Tissue-MicroArray-Hematoxylin-&-Eosin-Stain-NBP2-30169-img0075.jpg)
![Hematoxylin & Eosin Stain: Human Prostate Cancer Tissue MicroArray [NBP2-30169] - 26. Prostate adenocarcinoma](http://images.novusbio.com/fullsize/Human-Prostate-Cancer-Tissue-MicroArray-Hematoxylin-&-Eosin-Stain-NBP2-30169-img0076.jpg)
![Hematoxylin & Eosin Stain: Human Prostate Cancer Tissue MicroArray [NBP2-30169] - 27. Prostate adenocarcinoma](http://images.novusbio.com/fullsize/Human-Prostate-Cancer-Tissue-MicroArray-Hematoxylin-&-Eosin-Stain-NBP2-30169-img0077.jpg)
![Hematoxylin & Eosin Stain: Human Prostate Cancer Tissue MicroArray [NBP2-30169] - 28. Prostate adenocarcinoma](http://images.novusbio.com/fullsize/Human-Prostate-Cancer-Tissue-MicroArray-Hematoxylin-&-Eosin-Stain-NBP2-30169-img0078.jpg)
![Hematoxylin & Eosin Stain: Human Prostate Cancer Tissue MicroArray [NBP2-30169] - 29. Prostate adenocarcinoma](http://images.novusbio.com/fullsize/Human-Prostate-Cancer-Tissue-MicroArray-Hematoxylin-&-Eosin-Stain-NBP2-30169-img0079.jpg)
![Hematoxylin & Eosin Stain: Human Prostate Cancer Tissue MicroArray [NBP2-30169] - 30. Prostate adenocarcinoma](http://images.novusbio.com/fullsize/Human-Prostate-Cancer-Tissue-MicroArray-Hematoxylin-&-Eosin-Stain-NBP2-30169-img0080.jpg)
![Hematoxylin & Eosin Stain: Human Prostate Cancer Tissue MicroArray [NBP2-30169] - 31. Prostate adenocarcinoma](http://images.novusbio.com/fullsize/Human-Prostate-Cancer-Tissue-MicroArray-Hematoxylin-&-Eosin-Stain-NBP2-30169-img0081.jpg)
![Hematoxylin & Eosin Stain: Human Prostate Cancer Tissue MicroArray [NBP2-30169] - 32. Prostate adenocarcinoma](http://images.novusbio.com/fullsize/Human-Prostate-Cancer-Tissue-MicroArray-Hematoxylin-&-Eosin-Stain-NBP2-30169-img0082.jpg)
![Hematoxylin & Eosin Stain: Human Prostate Cancer Tissue MicroArray [NBP2-30169] - 33. Prostate adenocarcinoma](http://images.novusbio.com/fullsize/Human-Prostate-Cancer-Tissue-MicroArray-Hematoxylin-&-Eosin-Stain-NBP2-30169-img0083.jpg)
![Hematoxylin & Eosin Stain: Human Prostate Cancer Tissue MicroArray [NBP2-30169] - 34. Prostate adenocarcinoma](http://images.novusbio.com/fullsize/Human-Prostate-Cancer-Tissue-MicroArray-Hematoxylin-&-Eosin-Stain-NBP2-30169-img0084.jpg)
![Hematoxylin & Eosin Stain: Human Prostate Cancer Tissue MicroArray [NBP2-30169] - 35. Prostate adenocarcinoma](http://images.novusbio.com/fullsize/Human-Prostate-Cancer-Tissue-MicroArray-Hematoxylin-&-Eosin-Stain-NBP2-30169-img0085.jpg)
![Hematoxylin & Eosin Stain: Human Prostate Cancer Tissue MicroArray [NBP2-30169] - 36. Prostate adenocarcinoma](http://images.novusbio.com/fullsize/Human-Prostate-Cancer-Tissue-MicroArray-Hematoxylin-&-Eosin-Stain-NBP2-30169-img0086.jpg)
![Hematoxylin & Eosin Stain: Human Prostate Cancer Tissue MicroArray [NBP2-30169] - 37. Prostate adenocarcinoma](http://images.novusbio.com/fullsize/Human-Prostate-Cancer-Tissue-MicroArray-Hematoxylin-&-Eosin-Stain-NBP2-30169-img0087.jpg)
![Hematoxylin & Eosin Stain: Human Prostate Cancer Tissue MicroArray [NBP2-30169] - 38. Prostate adenocarcinoma](http://images.novusbio.com/fullsize/Human-Prostate-Cancer-Tissue-MicroArray-Hematoxylin-&-Eosin-Stain-NBP2-30169-img0088.jpg)
![Hematoxylin & Eosin Stain: Human Prostate Cancer Tissue MicroArray [NBP2-30169] - 39. Prostate adenocarcinoma](http://images.novusbio.com/fullsize/Human-Prostate-Cancer-Tissue-MicroArray-Hematoxylin-&-Eosin-Stain-NBP2-30169-img0089.jpg)
![Hematoxylin & Eosin Stain: Human Prostate Cancer Tissue MicroArray [NBP2-30169] - 40. Prostate adenocarcinoma](http://images.novusbio.com/fullsize/Human-Prostate-Cancer-Tissue-MicroArray-Hematoxylin-&-Eosin-Stain-NBP2-30169-img0090.jpg)
![Hematoxylin & Eosin Stain: Human Prostate Cancer Tissue MicroArray [NBP2-30169] - 41. Prostate Normal (match of #8)](http://images.novusbio.com/fullsize/Human-Prostate-Cancer-Tissue-MicroArray-Hematoxylin-&-Eosin-Stain-NBP2-30169-img0092.jpg)
![Hematoxylin & Eosin Stain: Human Prostate Cancer Tissue MicroArray [NBP2-30169] - 42.Prostate normal (match of #9)](http://images.novusbio.com/fullsize/Human-Prostate-Cancer-Tissue-MicroArray-Hematoxylin-&-Eosin-Stain-NBP2-30169-img0091.jpg)
![Hematoxylin & Eosin Stain: Human Prostate Cancer Tissue MicroArray [NBP2-30169] - 43. Prostate Normal](http://images.novusbio.com/fullsize/Human-Prostate-Cancer-Tissue-MicroArray-Hematoxylin-&-Eosin-Stain-NBP2-30169-img0093.jpg)
![Hematoxylin & Eosin Stain: Human Prostate Cancer Tissue MicroArray [NBP2-30169] - 44. Prostate Normal](http://images.novusbio.com/fullsize/Human-Prostate-Cancer-Tissue-MicroArray-Hematoxylin-&-Eosin-Stain-NBP2-30169-img0094.jpg)
![Hematoxylin & Eosin Stain: Human Prostate Cancer Tissue MicroArray [NBP2-30169] - 45. Prostate Normal](http://images.novusbio.com/fullsize/Human-Prostate-Cancer-Tissue-MicroArray-Hematoxylin-&-Eosin-Stain-NBP2-30169-img0095.jpg)
![Hematoxylin & Eosin Stain: Human Prostate Cancer Tissue MicroArray [NBP2-30169] - 46. Prostate normal (match of #19)](http://images.novusbio.com/fullsize/Human-Prostate-Cancer-Tissue-MicroArray-Hematoxylin-&-Eosin-Stain-NBP2-30169-img0096.jpg)
![Hematoxylin & Eosin Stain: Human Prostate Cancer Tissue MicroArray [NBP2-30169] - 47. Prostate Normal](http://images.novusbio.com/fullsize/Human-Prostate-Cancer-Tissue-MicroArray-Hematoxylin-&-Eosin-Stain-NBP2-30169-img0097.jpg)
![Hematoxylin & Eosin Stain: Human Prostate Cancer Tissue MicroArray [NBP2-30169] - 49. Prostate normal (match of #40)](http://images.novusbio.com/fullsize/Human-Prostate-Cancer-Tissue-MicroArray-Hematoxylin-&-Eosin-Stain-NBP2-30169-img0098.jpg)
![Hematoxylin & Eosin Stain: Human Prostate Cancer Tissue MicroArray [NBP2-30169] - 48. Prostate Normal](http://images.novusbio.com/fullsize/Human-Prostate-Cancer-Tissue-MicroArray-Hematoxylin-&-Eosin-Stain-NBP2-30169-img0099.jpg)
![Western Blot: IL-6 Antibody [NB600-1131] - Western Blot: IL-6 Antibody [HRP] [NBP1-42762] - Lane 1: Human IL-6. Lane 2: none. Load: 50 ng per lane. Primary antibody: none. Secondary antibody: Peroxidase Human IL-6 secondary antibody at 1:1,000 for 60 min at RT. Block: incubated with blocking buffer for 30 min at RT. Predicted/Observed size: 20 kDa for Human IL-6. Other band(s): none. Image using the HRP form of this antibody.](http://images.novusbio.com/fullsize/IL-6-Antibody-Western-Blot-NB600-1131-img0014.jpg "Western Blot: IL-6 Antibody [NB600-1131] - Western Blot: IL-6 Antibody [HRP] [NBP1-42762] - Lane 1: Human IL-6. Lane 2: none. Load: 50 ng per lane. Primary antibody: none. Secondary antibody: Peroxidase Human IL-6 secondary antibody at 1:1,000 for 60 min at RT. Block: incubated with blocking buffer for 30 min at RT. Predicted/Observed size: 20 kDa for Human IL-6. Other band(s): none. Image using the HRP form of this antibody.")
![Immunohistochemistry: IL-6 Antibody [NB600-1131] - GBM ECs express IL-6. Mouse GBM was induced by orthotopic injection of GL26 glioma cells into wild-type mouse. The brain sections that include normal brains and tumors were stained with anti-CD31, anti-IL-6, and anti-CSF-1 antibodies. Representative immunofluorescence images are shown. Right, enlarged area in normal and tumor tissues. Bar represents 50?um. Zoom-in factor: 4 Image collected and cropped by CiteAb from the following publication (//www.nature.com/articles/s41467-018-03050-0) licensed under a CC-BY license.](http://images.novusbio.com/fullsize/IL-6-Antibody-Immunocytochemistry-Immunofluorescence-NB600-1131-img0015.jpg)
![Western Blot: IL-6 Antibody [NB600-1131] - Protein was resolved on a 4-20% Tris-Glycine gel by SDS-PAGE and transferred onto nitrocellulose. The blot shows detection of a band 21 kDa in size corresponding to anti-IL6 antibody. Molecular weight markers are also shown (MW). After transfer, the membrane was blocked for 30 minutes with 1% BSA-TBST. Detection occurred using peroxidase conjugated anti-Rabbit IgG secondary antibody diluted 1:40,000 in blocking buffer for 30 min at RT followed by reaction with FemtoMax chemiluminescent substrate.](http://images.novusbio.com/fullsize/IL-6-Antibody-Western-Blot-NB600-1131-img0013.jpg)
![Immunocytochemistry/ Immunofluorescence: IL-6 Antibody [NB600-1131] - GBM ECs express IL-6. a Human brain ECs were treated with glioma-CM for 24 h, & cell lysates were subjected to multiplex cytokine array analysis. Left, a representative blot. Right, quantified dot intensity of most significantly changed cytokines. b Human microvascular brain ECs were treated with glioma-CM that were harvested from different human glioma cells. Cell lysates were immunoblotted. c Human microvascular brain ECs & tumor-associated ECs isolated from different GBM patients were subjected to immunoblot analysis. d Mouse GBM was induced by orthotopic injection of GL26 glioma cells into wild-type mouse. The brain sections that include normal brains & tumors were stained with anti-CD31, anti-IL-6, & anti-CSF-1 antibodies. Representative immunofluorescence images are shown. Right, enlarged area in normal & tumor tissues. Bar represents 50 μm. Zoom-in factor: 4 Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/29422647), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nb600-1131_rabbit-polyclonal-il-6-antibody-310202416154648.jpg)
![Hematoxylin & Eosin Stain: Esophagus Tissue Slides (Normal) [NBP2-30178] - esophagus, normal Age/Sex : 33/F](http://images.novusbio.com/fullsize/Esophagus-Tissue-Slides-Normal-Hematoxylin-&-Eosin-Stain-NBP2-30178-img0002.jpg "Hematoxylin & Eosin Stain: Esophagus Tissue Slides (Normal) [NBP2-30178] - esophagus, normal Age/Sex : 33/F")
![Western Blot: TNF-alpha Antibody (2342C) - Low Endotoxin and Azide Free [NBP2-75925] - Western blot shows conditioned media from CHO Chinese hamster ovary cell line either mock transfected or transfected with human TNF- alpha. PVDF membrane was probed with 2 ug/mL of Rabbit Anti-Human TNF-alpha Monoclonal Antibody (NBP2-75925) followed by HRP-conjugated Anti-Rabbit IgG Secondary Antibody (Catalog # HAF008). Specific bands were detected for TNF-alpha at approximately 18 and 21 kDa (as indicated). This experiment was conducted under reducing conditions.](http://images.novusbio.com/fullsize/TNF-alpha-Antibody-2342C-Low-Endotoxin-and-Azide-Free-Western-Blot-NBP2-75925-img0002.jpg "Western Blot: TNF-alpha Antibody (2342C) - Low Endotoxin and Azide Free [NBP2-75925] - Western blot shows conditioned media from CHO Chinese hamster ovary cell line either mock transfected or transfected with human TNF- alpha. PVDF membrane was probed with 2 ug/mL of Rabbit Anti-Human TNF-alpha Monoclonal Antibody (NBP2-75925) followed by HRP-conjugated Anti-Rabbit IgG Secondary Antibody (Catalog # HAF008). Specific bands were detected for TNF-alpha at approximately 18 and 21 kDa (as indicated). This experiment was conducted under reducing conditions.")
![Immunohistochemistry-Paraffin: TNF-alpha Antibody (2342C) - Low Endotoxin and Azide Free [NBP2-75925] - Analysis of a FFPE tissue section of the human intesting using 1:200 dilution of TNF-alpha antibody (NBP2-75925). The signal was developed using HRP-DAB method which followed counterstaining of the cells with hematoxylin. The antibody generated a moderate to strong cytoplasmic staining in crypt cells.](http://images.novusbio.com/fullsize/TNF-alpha-Antibody-2342C-Low-Endotoxin-and-Azide-Free-Immunohistochemistry-Paraffin-NBP2-75925-img0003.jpg)
![Neutralization: TNF-alpha Antibody (2342C) [NBP2-75925] - Recombinant Human TNF-alpha (Catalog # 210-TA) induces cytotoxicity in the the L-929 mouse fibroblast cell line in a dose-dependent manner (orange line), as measured by Resazurin (Catalog # AR002). Cytotoxicity elicited by Recombinant Human TNF-alpha (0.25 ng/mL) is neutralized (green line) by increasing concentrations of Mouse Anti-Human TNF-alpha Monoclonal Antibody (Catalog # NBP2-75925). The ND50 is typically 1-10 ng/mL in the presence of the metabolic inhibitor actinomycin D.](http://images.novusbio.com/fullsize/TNF-alpha-Antibody-2342C-Neutralization-NBP2-75925-img0001.jpg)
![Hematoxylin & Eosin Stain: Lung Tissue Slides (Adenocarcinoma) [NBP2-30279] - adenocarcinoma, moderated differentiated type, papillary Age/Sex : 62/M](http://images.novusbio.com/fullsize/Human-Lung-Tissue-Microarray-Adenocarcinoma-Immunohistochemistry-Paraffin-NBP2-30279-img0001.jpg "Hematoxylin & Eosin Stain: Lung Tissue Slides (Adenocarcinoma) [NBP2-30279] - adenocarcinoma, moderated differentiated type, papillary Age/Sex : 62/M")
![Hematoxylin & Eosin Stain: BALBc-adrenal gland tissue Tissue Slides (Normal) [NBP2-30173] - Aderenal gland, normal. Age/Sex: 58/M](http://images.novusbio.com/fullsize/BALBc-adrenal-gland-tissue-Tissue-Slides-Normal-Hematoxylin-&-Eosin-Stain-NBP2-30173-img0002.jpg "Hematoxylin & Eosin Stain: BALBc-adrenal gland tissue Tissue Slides (Normal) [NBP2-30173] - Aderenal gland, normal. Age/Sex: 58/M")
![Hematoxylin & Eosin Stain: Colon adenocarcinoma tissue Tissue Slides (Adenocarcinoma) [NBP2-61407]](http://images.novusbio.com/fullsize/Colon-adenocarcinoma-tissue-Tissue-Slides-Adenocarcinoma-Immunohistochemistry-Paraffin-NBP2-61407-img0001.jpg "Hematoxylin & Eosin Stain: Colon adenocarcinoma tissue Tissue Slides (Adenocarcinoma) [NBP2-61407]")
![Hematoxylin & Eosin Stain: Lung Matched Tumor & Normal Tissue Slides (Tumor) [NBP2-77666] - Tissue: Human Lung Tumor, Pathology: Primary Tumor](http://images.novusbio.com/fullsize/Lung-Matched-Tumor-&-Normal-Tissue-Slides-Tumor-Hematoxylin-&-Eosin-Stain-NBP2-77666-img0002.jpg "Hematoxylin & Eosin Stain: Lung Matched Tumor & Normal Tissue Slides (Tumor) [NBP2-77666] - Tissue: Human Lung Tumor, Pathology: Primary Tumor")
![Hematoxylin & Eosin Stain: Lung Matched Tumor & Normal Tissue Slides (Tumor) [NBP2-77666] - Tissue: Human Lung Tumor, Pathology: Matched Metastatic Tumor](http://images.novusbio.com/fullsize/Lung-Matched-Tumor-&-Normal-Tissue-Slides-Tumor-Hematoxylin-&-Eosin-Stain-NBP2-77666-img0001.jpg)
![Hematoxylin & Eosin Stain: Liver Matched Tumor & Normal Tissue Slides (Tumor) [NBP2-77665] - Tissue: Human Liver Tumor, Pathology: Primary Tumor](http://images.novusbio.com/fullsize/Liver-Matched-Tumor-&-Normal-Tissue-Slides-Tumor-Hematoxylin-&-Eosin-Stain-NBP2-77665-img0002.jpg "Hematoxylin & Eosin Stain: Liver Matched Tumor & Normal Tissue Slides (Tumor) [NBP2-77665] - Tissue: Human Liver Tumor, Pathology: Primary Tumor")
![Hematoxylin & Eosin Stain: Liver Matched Tumor & Normal Tissue Slides (Tumor) [NBP2-77665] - Tissue: Human Liver Tumor, Pathology: Matched Metastatic Tumor](http://images.novusbio.com/fullsize/Liver-Matched-Tumor-&-Normal-Tissue-Slides-Tumor-Hematoxylin-&-Eosin-Stain-NBP2-77665-img0001.jpg)